Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Jiangxi Rimag Group (2522 HK)
Watchlist
6
Analysis
Health Care
•
China
Jiangxi Rimag Group Co., Ltd. offers medical imaging services. The Company provides imaging center services, imaging solution services, rimag cloud services, and other services. Jiangxi Rimag Group provides its services throughout Hong Kong.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Jiangxi Rimag Group
•
13 Aug 2024 16:38
•
Broker
Rimag Group (2522 HK) - A Leading Medical Imaging Service Provider in China
According to Frost & Sullivan (F&S), the Company was the largest medical group specialized in medical imaging in China in 2023 in terms of medical...
CMB International
Follow
156 Views
Share
bullish
•
Jiangxi Rimag Group
•
31 May 2024 18:44
Jiangxi Rimag IPO (2522.HK): Global Offering and Valuation Update
I believe that Jiangxi Rimag is the best pure-play way to invest in a third-party medical imaging center market in Mainland China. The company is...
Andrei Zakharov
Follow
419 Views
Share
bearish
•
Jiangxi Rimag Group
•
29 May 2024 08:55
Pre-IPO Jiangxi Rimag Group (PHIP Updates) - Some Points Worth the Attention
Rimag would face challenges due to increasing competition and potential growth bottlenecks, despite recent profit turnaround. Investors need to be...
Xinyao (Criss) Wang
Follow
362 Views
Share
bullish
•
Jiangxi Rimag Group
•
27 May 2024 03:51
Jiangxi Rimag IPO: FCF Generation and Margin Expansion. Expect ~30 New Imaging Centers By 2026
Jiangxi Rimag Group restarted Hong Kong IPO and plans to raise capital for expanding medical imaging center network in Mainland China and overseas...
Andrei Zakharov
Follow
289 Views
Share
bearish
•
Jiangxi Rimag Group
•
07 Dec 2023 08:55
Pre-IPO Jiangxi Rimag Group - Unclear Profit Model, Uncertain Future Expansion, and Worrying Outlook
Although there's demand in grassroots market, profit/expansion model of third-party medical imaging services is unclear, leading to unsatisfactory...
Xinyao (Criss) Wang
Follow
322 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x